Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health, the US, have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease models.
The COVAX vaccine-sharing program said on Tuesday it will deliver 237 million doses of AstraZeneca's COVID-19 shot to 142 countries by the end of May as it steps up the global roll-out of its vaccine supplies.
Deputy Head of Razi Serum Research and Production Institute Dr. Mohammad Hassan Fallah-Mehrabadi said here on Tuesday that simultaneous with the last human testing phases of Razi Covo Pars COVID-19 Vaccine launching of its mass production line, too, was approved.
Rich countries are on course to have over a billion more doses of COVID-19 vaccines than they need, leaving poorer nations scrambling for leftover supplies as the world seeks to curb the coronavirus pandemic, a report by anti-poverty campaigners found.
Iran’s Ambassador to the United Nations Majid Takht-Ravanchi said that a successful fight against COVID-19 requires providing assistance to developing countries, equitable distribution of vaccines among world nations, and the removal of sanctions.